Dr. Ilya Tsimafeyeu is an internationally recognized authority in kidney cancer and one of the foremost specialists in the field. With a distinguished career spanning clinical care, research, education, and global leadership, he has made major contributions to advancing the treatment and understanding of renal malignancies worldwide.
Dr. Tsimafeyeu has held prominent roles across leading professional organizations dedicated to kidney cancer. He has served on expert councils and organizing committees for the Kidney Cancer Association (USA), Kidney Cancer Research Bureau (Russia), Kidney Cancer Patient League (Russia–Belarus–Ukraine), the VHL Alliance (USA), and the International Kidney Cancer Coalition (IKCC). He played a pioneering role in establishing modern oncology structures in his region, including co-founding the Russian Society of Clinical Oncology, where he served as its first director. He also led the Institute of Oncology at Hadassah Medical Moscow, shaping its clinical and academic programs.
An active contributor to global oncology education, Dr. Tsimafeyeu is a faculty member of the College of the European School of Oncology (ESCO, Italy) and serves on the ASCO Central and Eastern Europe Regional Council, supporting international collaboration and professional development. He is also a member of the editorial boards of the Kidney Cancer Journal (USA) and OncoDaily, where he helps disseminate critical updates in cancer research and care.
His achievements have been recognized through several prestigious awards, including the ASCO Merit Award, the ASCO IDEA Award, and the Prix Galien Award—one of the highest honors in biomedical innovation. Dr. Tsimafeyeu’s scientific work spans clinical trials, drug development, and translational oncology, with a focus on improving therapeutic strategies and outcomes for patients with kidney cancer.
Widely respected for his leadership, innovation, and commitment to evidence-based care, Dr. Ilya Tsimafeyeu continues to advance global standards in renal oncology and remains deeply dedicated to improving the lives of patients worldwide.
He is a Member of the Editorial Board of OncoDaily.